Angelina’s Impact: Genetic Counselors Share

BRCA mutation

Posts Tagged ‘BRCA mutation’

Angelina’s Impact: Genetic Counselors Share

It’s been five years since Angelina Jolie announced to the world she carries a BRCA1 mutation and had a prophylactic double mastectomy to lower her risks of developing breast cancer. Below genetic counselors reflect on the impact she has made by sharing her story and starting widespread conversation about hereditary cancer and prevention. “Angelina Jolie’s…

Read More

4 Years Post-Gene Patents: How Has Life Changed In The Genomics World?

Four years ago today, in a landmark decision, the Supreme Court of the United States, in a unanimous 9-0 decision banned gene patents.  What has changed in the genomics world in these past four years?  And what changes are yet to come? Within 5 hours of the decision, laboratories began offering genetic testing for mutations…

Read More

Angelina's Impact: Genetic Counselors Share

It’s been three years since Angelina Jolie announced to the world she carries a BRCA1 mutation and had a prophylactic double mastectomy to lower her risks of developing breast cancer. Below genetic counselors reflect on the impact she has made by sharing her story and starting widespread conversation about hereditary cancer and prevention. “Angelina Jolie’s…

Read More

Beyond BRCA: Testing negative and living in the 'gray zone' for cancer risk

This is Stacey’s story of searching for a genetic explanation for the prevalence of breast cancer in her family. Genetic Counseling Note: When a patient tests ‘negative’ for genetic mutations, part of the genetic counseling process is to interpret what that result means in light of the patient’s personal and family history. In some cases it…

Read More

Podcast: I Will Survive!

Today’s podcast is a survival story meant to remind us that in the midst of cancer their is hope. In this conversation, Joan shares her story of early an onset Stage II breast cancer diagnosis at 27, genetic testing and a BRCA mutation at 42 and Stage IIIA ovarian cancer at age 47. Speaking now…

Read More

Has the BRCA Monopoly Been Reborn?

A controversy has been brewing under the surface for several months in the genetic testing world. Namely, will BRCA carriers with ovarian cancer be forced to undergo BRCA testing a second time – at >$4000 a pop – in order to qualify for a new drug called Olaparib. Why? The FDA has approved PARP-inhibitor Olaparib for…

Read More